| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | GPCR GPR87 Blocking Peptide is synthetically produced from the 1-60 sequence and is suitable for use in western blot applications. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Dilution Range: | WB: IHC: 1:100 |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: | GPR87 |
| Gene ID: | 53836 |
| Uniprot ID: | GPR87_HUMAN |
| Immunogen Region: | 1-60 |
| Immunogen: | Synthetic peptide taken within amino acid region 1-60 on human GPCR87 protein. |
| Tissue Specificity | Expressed in placenta and prostate. Weaker expression in thymus. Not expressed in thalamus, hippocampus, pons or cerebellum. Overexpressed in squamous cell carcinoma of the lung. |
| Function | Receptor for lysophosphatidic acid (LPA). Necessary for p53/TP53-dependent survival in response to DNA damage. |
| Peptide Name | G-Protein Coupled Receptor 87G-Protein Coupled Receptor 95 |
| Cellular Localisation | Cell MembraneMulti-Pass Membrane Protein |
| Alternative Peptide Names | G-Protein Coupled Receptor 87 proteinG-Protein Coupled Receptor 95 proteinGPR87 proteinGPR95 proteinFKSG78 protein |
Information sourced from Uniprot.org